Loading fund overlap…
4 of 92 unique stocks in common · Jaccard: 4.3%
A weighted portfolio overlap of 5.88% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹5.88 is allocated to the exact same companies at the same relative proportions. The schemes share 4 common holdings.
The largest overlapping asset in their portfolios is Dr. Reddy's Laboratories, which commands a weight of 3.56% in and 2.36% in ICICI Prudential India Opportunities Fund. Holding both schemes increases your concentration in Dr. Reddy's Laboratories rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in | in ICICI |
|---|---|---|
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 3.56% | 2.36% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 10.99% | 1.88% |
| Gland PharmaPharmaceuticals & Biotechnology | 1.32% | 1.01% |
| CiplaPharmaceuticals & Biotechnology | 4.38% | 0.62% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.